Escherichia coli (E coli) Infections Medication: Antibiotics, Cephalosporins, 3rd Generation, Penicillins, Amino, Penicillins, Extended-Spectrum, Fluoroquinolones, Tetracyclines, Sulfonamides, Monobactams, Carbapenems (2024)

  1. Bennett JE, Dolin R, Blaser MJ. Enterobacteriaceae. Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases. 9th. Philadelphia, PA: Elsevier; 2020. 2673.

  2. Bennett JE, Dolin R, Blaser MJ. Enterobacteriaceae. Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases. 9th. Philadelphia, PA: Elsevier; 2020. 2679.

  3. Kermorvant-duch*emin, E; Laborie, S; Rabilloud, M; Lapillonne, A; Claris, O. Outcome and prognostic factors in neonates with septic shock. Pediatric Critical Care Medicine. March 2008. 9:186-191. [QxMD MEDLINE Link]. [Full Text].

  4. Khadka, P, Khadka P, Thapaliya, J, Bikram Karkee, et al. Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease. JMM Case Reports. Sep 2018. 5:[QxMD MEDLINE Link]. [Full Text].

  5. Medina, M; Castillo-Pino, E. An introduction to the epidemiology and burden of urinary tract infections. Therapeutic Advances in Urology. 02May2019. [QxMD MEDLINE Link]. [Full Text].

  6. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011 Nov 10. 365(19):1771-80. [QxMD MEDLINE Link].

  7. Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med. 2011 Nov 10. 365(19):1763-70. [QxMD MEDLINE Link].

  8. Camins BC, Marschall J, De Vader SR, Maker DE, Hoffman MW, Fraser VJ. The clinical impact of fluoroquinolone resistance in patients with E coli bacteremia. J Hosp Med. 2011 Jul. 6(6):344-9. [QxMD MEDLINE Link]. [Full Text].

  9. Walmsley RS, David DB, Allan RN, Kirkby GR. Bilateral endogenous Escherichia coli endophthalmitis: a devastating complication in an insulin-dependent diabetic. Postgrad Med J. 1996 Jun. 72(848):361-3. [QxMD MEDLINE Link].

  10. [Guideline] Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine. October 2019. 200:e45-e67. [Full Text].

  11. [Guideline] Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 21 March 2019. 68:e83-e110. [Full Text].

  12. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jan 15. 50 (2):133-64. [QxMD MEDLINE Link].

  13. McGannon CM, Fuller CA, Weiss AA. Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother. 2010 Sep. 54(9):3790-8. [QxMD MEDLINE Link].

  14. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008 Mar. 8(3):159-66. [QxMD MEDLINE Link].

  15. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect. 2007 Sep. 55(3):254-9. [QxMD MEDLINE Link].

  16. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum ß-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013 Mar. 56(5):641-8. [QxMD MEDLINE Link]. [Full Text].

  17. Batard E, Ollivier F, Boutoille D, Hardouin JB, Montassier E, Caillon J, et al. Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli. Int J Infect Dis. 2012 Nov 22. [QxMD MEDLINE Link].

  18. Karlowsky JA, Denisuik AJ, Lagacé-Wiens PR, Adam HJ, Baxter MR, Hoban DJ, et al. In Vitro Activity of Fosfomycin against Escherichia coli Isolated from Patients with Urinary Tract Infections in Canada; CANWARD Surveillance Study. Antimicrob Agents Chemother. 2013 Dec 9. [QxMD MEDLINE Link].

  19. Agustin ET, Gill V, Domenico P. CSF gram stain in meningitis. Intern Med. 1994. 15:14-24.

  20. Barnett BJ, Stephens DS. Urinary tract infection: an overview. Am J Med Sci. 1997 Oct. 314(4):245-9. [QxMD MEDLINE Link].

  21. Boam WD, Miser WF. Acute focal bacterial pyelonephritis. Am Fam Physician. 1995 Sep 1. 52(3):919-24. [QxMD MEDLINE Link].

  22. Bohnen JM. Antibiotic therapy for abdominal infection. World J Surg. 1998 Feb. 22(2):152-7. [QxMD MEDLINE Link].

  23. Bonoan JT, Mehra S, Cunha BA. Emphysematous pyelonephritis. Heart Lung. 1997 Nov-Dec. 26(6):501-3. [QxMD MEDLINE Link].

  24. Carpenter HA. Bacterial and parasitic cholangitis. Mayo Clin Proc. 1998 May. 73(5):473-8. [QxMD MEDLINE Link].

  25. Childs SJ. Current concepts in the treatment of urinary tract infections and prostatitis. Am J Med. 1991 Dec 30. 91(6A):120S-123S. [QxMD MEDLINE Link].

  26. Cunha BA. Abdominal pain in patients with diabetis mellitus. Infect Dis Prac. 1997. 21:14-5.

  27. Cunha BA. Acute acalculous cholecystitis. Infect Dis Prac. 1997. 21:70-1.

  28. Cunha BA. Acute and chronic bacterial prostatitis. Infect Dis Prac. 1994. 18:78-9.

  29. Cunha BA. Antibiotic concentration dependent susceptibility of urinary tract isolates. Antib Clinician. 1999. 3:57-8.

  30. Cunha BA. Quinolones: Clinical aspects. Antib Clinician. 1998. 2:129-35.

  31. Cunha BA. The fluoroquinolones for urinary tract infections: a review. Adv Ther. 1994 Nov-Dec. 11(6):277-96. [QxMD MEDLINE Link].

  32. Cunha BA. Therapeutic approach in treating UTIs. Antib Clinician. 1998. 2(S2):35-40.

  33. Cunha BA. Urine gram stain in urosepsis. Intern Med. 1997. 18:75-8.

  34. Cunha BA. Urosepsis. J Crit Ill. 1997. 12:616-25.

  35. Donnenberg MS, Kaper JB. Enteropathogenic Escherichia coli. Infect Immun. 1992 Oct. 60(10):3953-61. [QxMD MEDLINE Link].

  36. DuPont HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs. 2006. 66(3):303-14. [QxMD MEDLINE Link].

  37. Eisenstein BI, Jones GW. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern Med. 1988. 33:231-52. [QxMD MEDLINE Link].

  38. Glandt M, Adachi JA, Mathewson JJ, Jiang ZD, DiCesare D, Ashley D. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis. 1999 Aug. 29(2):335-8. [QxMD MEDLINE Link].

  39. Gold R. Bacterial meningitis--1982. Am J Med. 1983 Jul 28. 75(1B):98-101. [QxMD MEDLINE Link].

  40. Hansing CE, Allen VD, Cherry JD. Escherichia coli endocarditis. A review of the literature and a case study. Arch Intern Med. 1967 Oct. 120(4):472-7. [QxMD MEDLINE Link].

  41. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006 Jan. 254(1):12-8. [QxMD MEDLINE Link].

  42. Harvey D, Holt DE, Bedford H. Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. Semin Perinatol. 1999 Jun. 23(3):218-25. [QxMD MEDLINE Link].

  43. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991 Jan. 4(1):80-128. [QxMD MEDLINE Link].

  44. Jonas M, Cunha BA. Bacteremic Escherichia coli pneumonia. Arch Intern Med. 1982 Nov. 142(12):2157-9. [QxMD MEDLINE Link].

  45. Klein NC, Cunha BA. Third-generation cephalosporins. Med Clin North Am. 1995 Jul. 79(4):705-19. [QxMD MEDLINE Link].

  46. Koutkia P, Mylonakis E, Flanigan T. Enterohemorrhagic Escherichia coli O157:H7--an emerging pathogen. Am Fam Physician. 1997 Sep 1. 56(3):853-6, 859-61. [QxMD MEDLINE Link].

  47. Lepelletier D, Caroff N, Reynaud A, Richet H. Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains. Clin Infect Dis. 1999 Sep. 29(3):548-52. [QxMD MEDLINE Link].

  48. Lerner AM. The gram-negative bacillary pneumonias. Dis Mon. 1980 Nov. 27(2):1-56. [QxMD MEDLINE Link].

  49. McDonald MI. Pyogenic liver abscess: diagnosis, bacteriology and treatment. Eur J Clin Microbiol. 1984 Dec. 3(6):506-9. [QxMD MEDLINE Link].

  50. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet. 1998 Oct 10. 352(9135):1207-12. [QxMD MEDLINE Link].

  51. Moon HW. Pathogenesis of enteric diseases caused by Escherichia coli. Adv Vet Sci Comp Med. 1974. 18(0):179-211. [QxMD MEDLINE Link].

  52. Neu HC. Infections due to gram-negative bacteria: an overview. Rev Infect Dis. 1985 Nov-Dec. 7 Suppl 4:S778-82. [QxMD MEDLINE Link].

  53. Nordmann P. Trends in beta-lactam resistance among Enterobacteriaceae. Clin Infect Dis. 1998 Aug. 27 Suppl 1:S100-6. [QxMD MEDLINE Link].

  54. Ortega AM, Cunha BA. Acute prostatitis. Contemp Urol. 1997. 18:73-80.

  55. Palmer DL. Microbiology of pneumonia in the patient at risk. Am J Med. 1984 May 15. 76(5A):53-60. [QxMD MEDLINE Link].

  56. Phillips AD, Frankel G. Mechanisms of gut damage by Escherichia coli. Baillieres Clin Gastroenterol. 1997 Sep. 11(3):465-83. [QxMD MEDLINE Link].

  57. Roberts JA. Pyelonephritis, cortical abscess, and perinephric abscess. Urol Clin North Am. 1986 Nov. 13(4):637-45. [QxMD MEDLINE Link].

  58. Savatta D, Cunha BA. Acute pyelonephritis and its mimics: Xanthogranulomaotus pyelonephritis and malacoplakia. Infect Dis Prac. 1996. 20:86-8.

  59. Schimpff SC. Gram-negative bacteremia. Support Care Cancer. 1993 Jan. 1(1):5-18. [QxMD MEDLINE Link].

  60. Schindzielorz A, Edberg SC, Bia FJ. Strongyloides stercoralis hyperinfection and central nervous system involvement in a patient with relapsing polychondritis. South Med J. 1991 Aug. 84(8):1055-7. [QxMD MEDLINE Link].

  61. Shea KW, Cunha BA. Escherichia coli sternal osteomyelitis after open heart surgery. Heart Lung. 1995 Mar-Apr. 24(2):177-8. [QxMD MEDLINE Link].

  62. Tabacof J, Feher O, Katz A, et al. Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis. Cancer. 1991 Oct 15. 68(8):1821-3. [QxMD MEDLINE Link].

  63. Tan JS, File TM. Urinary tract infections in obstetrics and gynecology. J Reprod Med. 1990 Mar. 35(3 Suppl):339-42. [QxMD MEDLINE Link].

  64. Tenner SM, Yadven MW, Kimmel PL. Acute pyelonephritis. Preventing complications through prompt diagnosis and proper therapy. Postgrad Med. 1992 Feb 1. 91(2):261-8. [QxMD MEDLINE Link].

  65. Tice AD. Short-course therapy of acute cystitis: a brief review of therapeutic strategies. J Antimicrob Chemother. 1999 Mar. 43 Suppl A:85-93. [QxMD MEDLINE Link].

  66. Wanke CA. Escherichia coli. J Diarrhoeal Dis Res. 1988 Mar. 6(1):1-5. [QxMD MEDLINE Link].

  67. Weinberger M, Cytron S, Servadio C, et al. Prostatic abscess in the antibiotic era. Rev Infect Dis. 1988 Mar-Apr. 10(2):239-49. [QxMD MEDLINE Link].

  68. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs. 1999 Jan. 57(1):81-91. [QxMD MEDLINE Link].

  69. Whipp SC, Rasmussen MA, Cray WC Jr. Animals as a source of Escherichia coli pathogenic for human beings. J Am Vet Med Assoc. 1994 Apr 15. 204(8):1168-75. [QxMD MEDLINE Link].

Escherichia coli (E coli) Infections Medication: Antibiotics, Cephalosporins, 3rd Generation, Penicillins, Amino, Penicillins, Extended-Spectrum, Fluoroquinolones, Tetracyclines, Sulfonamides, Monobactams, Carbapenems (2024)
Top Articles
Latest Posts
Article information

Author: Delena Feil

Last Updated:

Views: 6335

Rating: 4.4 / 5 (65 voted)

Reviews: 88% of readers found this page helpful

Author information

Name: Delena Feil

Birthday: 1998-08-29

Address: 747 Lubowitz Run, Sidmouth, HI 90646-5543

Phone: +99513241752844

Job: Design Supervisor

Hobby: Digital arts, Lacemaking, Air sports, Running, Scouting, Shooting, Puzzles

Introduction: My name is Delena Feil, I am a clean, splendid, calm, fancy, jolly, bright, faithful person who loves writing and wants to share my knowledge and understanding with you.